APA

Shabto J. M., Martini D. J., Liu Y., Ravindranathan D., Brown J., Hitron E. E., Russler G. A., Caulfield S., Kissick H., Alemozaffar M., Ogan K., Harris W. B., Master V. A., Kucuk O., Carthon B. C. & Bilen M. A. (20210514). Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors. : Cancer medicine.

Chicago

Shabto Julie M, Martini Dylan J, Liu Yuan, Ravindranathan Deepak, Brown Jacqueline, Hitron Emilie E, Russler Greta A, Caulfield Sarah, Kissick Haydn, Alemozaffar Mehrdad, Ogan Kenneth, Harris Wayne B, Master Viraj A, Kucuk Omer, Carthon Bradley C and Bilen Mehmet A. 20210514. Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors. : Cancer medicine.

Harvard

Shabto J. M., Martini D. J., Liu Y., Ravindranathan D., Brown J., Hitron E. E., Russler G. A., Caulfield S., Kissick H., Alemozaffar M., Ogan K., Harris W. B., Master V. A., Kucuk O., Carthon B. C. and Bilen M. A. (20210514). Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors. : Cancer medicine.

MLA

Shabto Julie M, Martini Dylan J, Liu Yuan, Ravindranathan Deepak, Brown Jacqueline, Hitron Emilie E, Russler Greta A, Caulfield Sarah, Kissick Haydn, Alemozaffar Mehrdad, Ogan Kenneth, Harris Wayne B, Master Viraj A, Kucuk Omer, Carthon Bradley C and Bilen Mehmet A. Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors. : Cancer medicine. 20210514.